ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,339.23
-0.37%
Dow Jones
39,065.26
-1.53%
Gold vs US Dollar
2,332.14
-2.09%
Brent Oil
81.11
-0.52%
Bitcoin
66,732.08
-3.42%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Lorus Therapeutics, (New) (LRP)

  7. Lorus Therapeutics, (New) (LRP) News

Lorus Therapeutics (LRP)

Lorus Therapeutics, (New)
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:LRP
DateTimeSourceHeadlineSymbolCompany
21/10/201413:00PR Newswire (US)Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTOAMEX:LRPLorus Therapeutics, (New)
21/10/201413:00PR Newswire (Canada)Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTOAMEX:LRPLorus Therapeutics, (New)
03/10/201412:00PR Newswire (US)Aptose Biosciences to Present at the 2014 BIO Investor ForumAMEX:LRPLorus Therapeutics, (New)
03/10/201412:00PR Newswire (Canada)Aptose Biosciences to Present at the 2014 BIO Investor ForumAMEX:LRPLorus Therapeutics, (New)
01/10/201422:16PR Newswire (Canada)Aptose Biosciences Announces Reverse Stock SplitAMEX:LRPLorus Therapeutics, (New)
01/10/201422:16PR Newswire (US)Aptose Biosciences Announces Reverse Stock SplitAMEX:LRPLorus Therapeutics, (New)
29/09/201413:30PR Newswire (US)Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...AMEX:LRPLorus Therapeutics, (New)
29/09/201413:30PR Newswire (Canada)Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...AMEX:LRPLorus Therapeutics, (New)
25/09/201414:48PR Newswire (US)Aptose Biosciences to Present at Upcoming Investor ConferencesAMEX:LRPLorus Therapeutics, (New)
25/09/201414:48PR Newswire (Canada)Aptose Biosciences to Present at Upcoming Investor ConferencesAMEX:LRPLorus Therapeutics, (New)
08/09/201412:00PR Newswire (US)Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical OfficerAMEX:LRPLorus Therapeutics, (New)
08/09/201412:00PR Newswire (Canada)Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical OfficerAMEX:LRPLorus Therapeutics, (New)
02/09/201412:00PR Newswire (US)Lorus Therapeutics Implements Name Change to Aptose BiosciencesAMEX:LRPLorus Therapeutics, (New)
02/09/201412:00PR Newswire (Canada)Lorus Therapeutics Implements Name Change to Aptose BiosciencesAMEX:LRPLorus Therapeutics, (New)
19/08/201421:00PR Newswire (US)Lorus Therapeutics Announces Results of Annual and Special Meeting of ShareholdersAMEX:LRPLorus Therapeutics, (New)
19/08/201421:00PR Newswire (Canada)Lorus Therapeutics Announces Results of Annual and Special Meeting of ShareholdersAMEX:LRPLorus Therapeutics, (New)
07/08/201412:00PR Newswire (US)Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth ConferenceAMEX:LRPLorus Therapeutics, (New)
07/08/201412:00PR Newswire (Canada)Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth ConferenceAMEX:LRPLorus Therapeutics, (New)
28/07/201412:00PR Newswire (US)Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo...AMEX:LRPLorus Therapeutics, (New)
28/07/201412:00PR Newswire (Canada)Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo...AMEX:LRPLorus Therapeutics, (New)
15/07/201421:46PR Newswire (US)Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014AMEX:LRPLorus Therapeutics, (New)
15/07/201421:46PR Newswire (Canada)Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014AMEX:LRPLorus Therapeutics, (New)
15/07/201421:28PR Newswire (US)Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ ListingAMEX:LRPLorus Therapeutics, (New)
15/07/201421:28PR Newswire (Canada)Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ ListingAMEX:LRPLorus Therapeutics, (New)
10/07/201412:00PR Newswire (US)Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and WebcastAMEX:LRPLorus Therapeutics, (New)
10/07/201412:00PR Newswire (Canada)Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and WebcastAMEX:LRPLorus Therapeutics, (New)
19/06/201412:00PR Newswire (US)Lorus Therapeutics to Present at the 9th JMP Securities Healthcare ConferenceAMEX:LRPLorus Therapeutics, (New)
19/06/201412:00PR Newswire (Canada)Lorus Therapeutics to Present at the 9th JMP Securities Healthcare ConferenceAMEX:LRPLorus Therapeutics, (New)
16/06/201412:00PR Newswire (Canada)Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceAMEX:LRPLorus Therapeutics, (New)
16/06/201412:00PR Newswire (US)Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceAMEX:LRPLorus Therapeutics, (New)
 Showing the most relevant articles for your search:AMEX:LRP

Your Recent History

NYSE
UBH
Usb
NASDAQ
NATKC
North American
EU
EAIWP
Euronext AI World
BIT
S30582
Societe Generale Effekten
COIN
MYFICUSD
MyFiChain
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved